Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Inkretiner. / Vilsbøll, Tina; Holst, Jens Juul.

    Diabetes - sygdom, behandling og organisation. ed. / Jannik Hilsted; Knut Borch-Johnsen; Jens Sandahl Christiansen. 2. ed. København : Munksgaard , 2011. p. 67-74.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  2. Published

    Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion. / Witte, Anne-Barbara; Grybäck, Per; Jacobsson, Hans; Näslund, Erik; Hellström, Per Martin; Holst, Jens Juul; Hilsted, Linda; Schmidt, Peter Thelin.

    In: Scandinavian Journal of Gastroenterology. Supplement, Vol. 46, No. 4, 2011, p. 428-35.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    KU bestemmer selv over sin forskning. / Wewer, Ulla M.; Holst, Jens Juul; Schwartz, Thue W.; Quistorff, Bjørn.

    In: Universitetsavisen, 02.06.2011.

    Research output: Contribution to journalContribution to newspaper - Comment/debateCommunication

  4. Published

    Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events : Results from the Liraglutide Effect and Action in Diabetes (LEAD) trials. / Buse, John B; Garber, Alan; Rosenstock, Julio; Schmidt, Wolfgang E; Brett, Jason H; Videbæk, Nicoline; Holst, Jens Juul; Nauck, Michael.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 96, No. 6, 2011, p. 1695-702.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Lixisenatide for type 2 diabetes mellitus. / Christensen, Mikkel; Knop, Filip K; Vilsbøll, Tina; Holst, Jens Juul.

    In: Expert Opinion on Investigational Drugs, Vol. 20, No. 4, 2011, p. 549-57.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes. / Holst, Jens Juul; Knop, Filip K; Vilsbøll, Tina; Krarup, Thure; Madsbad, Sten.

    In: Diabetes Care, Vol. 34, No. Supplement 2, 05.2011, p. S251-7.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes. / Menge, Björn A; Grüber, Lena; Jørgensen, Signe M; Deacon, Carolyn F; Schmidt, Wolfgang E; Veldhuis, Johannes D; Holst, Jens Juul; Meier, Juris J.

    In: Diabetes, Vol. 60, No. 8, 08.2011, p. 2160-2168.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Mechanism-based population modelling for assessment of L-cell function based on total GLP-1 response following an oral glucose tolerance test. / Møller, Jonas B; Jusko, William J; Gao, Wei; Hansen, Torben; Pedersen, Oluf; Holst, Jens J; Overgaard, Rune Viig; Madsen, Henrik; Ingwersen, Steen H.

    In: Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, No. 6, 2011, p. 713-25.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Neuroprotective properties of GLP-1 : theoretical and practical applications. / Holst, Jens Juul; Burcelin, Remy; Nathanson, Esther.

    In: Current Medical Research and Opinion, Vol. 27, No. 3, 2011, p. 547-58.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential. / Torekov, S S; Madsbad, S; Holst, Jens Juul.

    In: Obesity Reviews, Vol. 12, No. 8, 2011, p. 593-601.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207